Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT04338360
Previous Study | Return to List | Next Study

Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04338360
Expanded Access Status : Approved for marketing
First Posted : April 8, 2020
Last Update Posted : September 2, 2020
Sponsor:
Information provided by (Responsible Party):
Michael J. Joyner, M.D., Mayo Clinic

Tracking Information
First Submitted Date April 3, 2020
First Posted Date April 8, 2020
Last Update Posted Date September 2, 2020
 
Descriptive Information
Brief Title Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19
Brief Summary This expanded access program will provide access to investigational convalescent plasma for patients in acute care facilities infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Detailed Description Not Provided
Study Type Expanded Access
Expanded Access Type Intermediate-size Population
Intervention Biological: COVID-19 convalescent plasma
COVID-19 convalescent plasma
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Expanded Access Status Approved for marketing
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT04338360
Responsible Party Michael J. Joyner, M.D., Mayo Clinic
Study Sponsor Mayo Clinic
Collaborators Not Provided
Investigators
Principal Investigator: Michael Joyner, MD Mayo Clinic
PRS Account Mayo Clinic
Verification Date August 2020